Kolon TissueGene, Inc. develops regenerative therapies for the treatment of orthopaedic diseases and degenerative disorders. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company